NEW YORK (TheStreet) -- CHANGE IN RATINGS
upgraded at UBS. Rating raised to Buy from Neutral. Price target raised to $70 from $63. Maintains 2009 EPS estimates of $4.88.
Black & Decker
initiated at Barclays with an Overweight rating and $55 price target. 2009 and 2010 EPS estimates set at $1.70 and $2.32, respectively.
reinstated at Merrill/BofA reinstated coverage on CLP with an Underperform rating and $9 price target on weak markets and slower growth.
upgraded at Jefferies to Hold. $40 price target. Valuation remains high, but channel checks suggest strong spending in the second half of the year.
Dr Pepper Snapple Group
downgraded at Deutsche Bank. Rating lowered to Hold from Buy. Price target raised to $32 from $31. Maintains 2009 EPS estimates of $1.94.
downgraded at Thomas Weisel to Market Weight from Overweight on valuation. Maintain $35 price target.
reinstated at Merrill/BofA reinstated coverage on GLW with a Buy rating and $19 price target as valuation appears attractive. 2009 2010 EPS estimates set at $1.26 and $1.56, respectively.
upgraded at BB&T to Buy. $117 price target. Company has solid cash flow, a strong balance sheet and should benefit from better industrial production.
upgraded at Credit Suisse to Outperform from Neutral on expected top line growth. Price target raised to $112 from $85. 2009 and 2010 EPS estimates set at $5.06 and $5.90, respectively.
upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $27 from $21. 2009 EPS estimates raised to $1.90 from $1.87.
upgraded at Credit Suisse to Outperform from Neutral. Price target lifted to $255 from $210. 2009 and 2010 EPS estimates set at $10.90 and $12.65, respectively.
estimate raised at Barclays. 2009 EPS estimate increased to $10.90 from $10.85. Maintain 2010 at $13.05. Reiterate $235 price target and Overweight rating.
initiated at Barclays with an Equal Weight rating and $14 price target. 2009 and 2010 EPS estimates set at -$0.12 and $0.28, respectively.
initiated at Barclays with an Equal Weight rating and $49 price target. 2009 and 2010 EPS estimates set at -$0.11 and $2.17, respectively.
upgraded at Jefferies from Hold to Buy. $46 price target. Valuation call, as the stock offers above-average growth potential with below-average risk.
Plum Creek Timber
upgraded at JP Morgan. Rating raised to Neutral from Underweight. Establishes $31 price target. Maintains 2009 EPS estimates of $1.38.
upgraded at Citigroup to Buy. $49 price target. Channel checks show that sales trends have improved.
initiated Merrill/BofA with a Buy rating and $52 price target. RKT has been one of the best run paper/packaging companies in recent years, said Bank of America/Merrill Lynch. 2009 and 2010 EPS estimates set at $4.62 and $4.40, respectively.
downgraded at UBS. Rating lowered to Sell from Neutral. Maintains $18 price target and 2009 EPS estimates of -$0.24.
upgraded at Jefferies from Hold to Buy. $19 price target. Expect IT security spending to pick up in the second half of the year.
upgraded at Credit Suisse to Outperform from Neutral as current price levels represent an attractive entry point. 2009 and 2010 EPS estimates set at $2.90 and $3.50, respectively. Price target boosted to $84 from $70.
upgraded at Jefferies from Underperform to Hold. $40 price target. Company should benefit improved virtualization spending.
STOCK COMMENTS / EPS CHANGES
target boosted at Citigroup to $26. New satellite should significantly add to earnings. Hold rating.
added to Conviction Sell list at Goldman. $32 price target. Valuation call, as the stock is already pricing in a successful recovery.
estimates, target raised at Goldman. Shares of GOOG now seen reaching $585. Estimates also boosted, to reflect higher expected ad spending. Buy rating.
price target boosted at Thomas Weisel to $620 from $530 on belief that the company is cyclical recovery play. 2009 and 2010 EPS estimates set at $21.78 and $24.75, respectively. Maintain Overweight rating.
numbers increased at UBS. Shares now seen reaching $55. Estimates were also boosted, given the company's operating leverage. Buy rating.
target raised at UBS to $125. Expect the company to keep exceeding earnings guidance. Neutral rating.
numbers raised at FBR. Shares now seen reaching $23. Estimates also boosted, to reflect positive sales momentum. Market Perform rating.
cut from Conviction Sell list at Goldman. Analyst meeting will likely be a positive catalyst. $20 price target.
estimates, target increased at UBS. KO estimates were raised through 2010. Company is seeing steady volume growth across the globe. Neutral rating and new $57 price target.
numbers cut at FBR to $94. Estimates were also lowered to reflect a delay in government services revenue. Outperform rating.
numbers increased at FBR. Target up to $22. Estimates also raised, to reflect improving economic trends. Underperform rating.
numbers increased at UBS. Shares now seen reaching $40. Estimates were also boosted, to reflect increased orders. Neutral rating.
numbers raised at Citigroup through 2011. Expect sales and margins to hit an inflection point in the fourth quarter. Buy rating and new $24 price target.
estimates raised at Goldman through 2011. Market is undervaluing the company's royalty stream. Buy rating and $54 price target.
estimates lowered at Citigroup through 2011. Company is seeing more downtime for its ultra-deepwater rigs. Buy rating and $100 price target.
numbers raised at FBR. Shares now seen reaching $28.50. Estimates also increased, to reflect improving industry fundamentals. Market Perform rating.
target boosted at Goldman to $34. Expect more M&A in the Medicaid space. Buy rating.
This article was written by a staff member of TheStreet.com.